MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Aclaris Therapeutics, Inc.

ACRS

#2714
Aclaris Therapeutics, Inc.
2.87
-8.01%
Sector:
Base:
Profit Currency:
Daily Range
2.87
2.87
Year Range
1.05
4.89
Daily Change
-8.01%
Monthly Change
-26.41%
6 month change
+56.83%
Year Change
+50.26%
Previous Close
3.12
Open
2.87
Bid
Ask
Low
2.87
High
2.87
Volume
58
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. ACRS
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

News

Investing Investing
ACRS
yesterday, 14:52
Stifel raises Aclaris Therapeutics stock price target to $3 on pipeline
Zacks Zacks
ACRS ZVRA
2 days ago, 14:45
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates
Investing Investing
ACRS
2 days ago, 13:02
Aclaris Therapeutics Inc earnings missed by $0.01, revenue fell short of estimates
Zacks Zacks
IONS ACRS
2026.02.25
Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates
Zacks Zacks
CORT ACRS
2026.02.25
Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates
Investing Investing
ACRS
2026.02.24
Aclaris starts phase 1b trial of ATI-052 in asthma patients
Investing Investing
ACRS
2026.01.30
Craig-Hallum initiates coverage on Aclaris Therapeutics stock with Buy rating
Investing Investing
ACRS
2026.01.28
Aclaris stock gets Buy rating reaffirmed by H.C. Wainwright after positive preclinical results
Benzinga Benzinga
ACRS PFE
2026.01.27
Aclaris Hair Loss Drug Shows Faster Results Than Pfizer's Drug - Aclaris Therapeutics (NASDAQ:ACRS)
Investing Investing
ACRS
2026.01.27
Aclaris reports positive preclinical results for hair loss drug
Investing Investing
UNH KO PG MMM IBM
2026.01.20
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.76%
Investing Investing
ACRS
2026.01.12
Aclaris begins phase 1b trial of ATI-052 for atopic dermatitis

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd